🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Ebix reaches restructuring agreement with consortium

Published 29/07/2024, 18:30
EBIXQ
-

In a significant development, Ebix Inc . (OTC:EBIXQ), a global provider of software and e-commerce solutions, has entered into a Second Amended Plan Support Agreement with a consortium comprising Eraaya Lifespaces Limited, Vikas Lifecare Limited, and Vitasta Software India Private Limited. This agreement, dated July 22, 2024, outlines the consortium's support for Ebix's chapter 11 plan of reorganization and a restructuring transaction.

The consortium will acquire 100% equity in the reorganized Ebix entities in exchange for a $145 million investment, alongside additional considerations. This move is part of Ebix's ongoing voluntary proceedings under the United States Bankruptcy Code, which were initiated on December 17, 2023, in the Northern District of Texas.

The agreement stipulates various milestones, including deposits into a designated escrow account totaling over $50 million by specific dates in July and August 2024. The Bankruptcy Court must also approve the reorganization plan by August 15, 2024, with the plan's effective date expected to occur no later than August 31, 2024.

Additionally, the agreement amends the breakup fee payable to the consortium under certain conditions, setting it at $4,350,000 or $2,900,000, depending on various factors. The Debtors and the Plan Sponsor are committed to implementing the restructuring transaction, although there can be no assurance that the reorganization or any similar transaction will be completed.

The Second Amended Plan Support Agreement is subject to court approval and other conditions. Despite the intention to pursue the restructuring transaction, Ebix cautions that trading in its securities is highly speculative and risky during the Chapter 11 proceedings.

This news is based on a press release statement.

InvestingPro Insights

In light of Ebix Inc.'s ongoing restructuring efforts, a glance at the company's financial health and market performance through InvestingPro's real-time data reveals a challenging landscape. The company's market capitalization stands at a mere $0.02 million, and a significantly negative revenue growth of -30.72% over the last twelve months as of Q3 2023 underscores the difficulties it faces. Moreover, the stock price has experienced an extreme downturn, with a total year-to-date return of -99.92%.

From the perspective of InvestingPro Tips, two insights stand out. Firstly, the stock's recent performance indicates it is in oversold territory, which could suggest a potential rebound if market sentiment shifts post-restructuring. Secondly, Ebix is trading at a low Price / Book multiple, which may attract investors looking for undervalued opportunities amidst the restructuring process.

For those considering an investment in Ebix or seeking a deeper understanding of its market position, InvestingPro offers a comprehensive suite of additional tips. By using the coupon code PRONEWS24, readers can get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription to access these valuable insights. Currently, there are 16 additional InvestingPro Tips available for Ebix, providing a broader context for informed decision-making.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.